Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:1643-1650
Published online before print April 14, 2008, doi: 10.1161/HYPERTENSIONAHA.107.109611
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
51/6/1643    most recent
HYPERTENSIONAHA.107.109611v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Staessen, J. A.
Right arrow Articles by Brand, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Staessen, J. A.
Right arrow Articles by Brand, E.
Related Collections
Right arrow Clinical genetics
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease

(Hypertension. 2008;51:1643.)
© 2008 American Heart Association, Inc.


Original Articles

Blood Pressure and Renal Sodium Handling in Relation to Genetic Variation in the DRD1 Promoter and GRK4

Jan A. Staessen; Tatiana Kuznetsova; Haifeng Zhang; Marc Maillard; Murielle Bochud; Sandra Hasenkamp; Judith Westerkamp; Tom Richart; Lutgarde Thijs; Xinli Li; Stefan-Martin Brand-Herrmann; Michel Burnier; Eva Brand

From the Genetic Epidemiology Unit, Department of Epidemiology (J.A.S., T.R.), University of Maastricht, The Netherlands; the Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases (J.A.S., T.K., H.Z., T.R., L.T.), University of Leuven, Belgium; the Department of Cardiology (H.Z., X.L.), the First Affiliated Hospital, Nanjing Medical University, Nanjing, China; the Division of Nephrology and Hypertension (M.M., M. Bochud, M. Burnier), University of Lausanne, Switzerland; the Department of Internal Medicine D (S.H., J.W., E.B.), Nephrology and Hypertension, University of Münster, Germany; and the Leibniz Institute for Arteriosclerosis Research (S.-M.B.-H.), Department of Molecular Genetics of Cardiovascular Disease, University of Münster, Germany.

Correspondence to Jan A. Staessen, Genetic Epidemiology Unit, Department of Epidemiology, Peter Debyeplein 1, P.O. Box 616, 6200 MD Maastricht, The Netherlands. E-mail ja.staessen{at}epid.unimaas.nl

Activation of type-1 dopamine receptors (DRD1) reduces renal sodium reabsorption. In a family-based random sample of 611 untreated whites (women, 45.0%; mean age, 38.6 years), we measured blood pressure (BP). We used the endogenous lithium clearance to assess fractional sodium excretion (FENa) and proximal (RNaprox) and distal (RNadist) tubular sodium reabsorption. We investigated multivariate-adjusted associations with the DRD1 promoter (A48G, G94A, and C800T) and GRK4 (Ala142Val). The frequent DRD1 haplotypes were AGC (48.2%), GGT (34.4%), and AAC (14.3%). While standardizing to mean sodium excretion (8.7 mmol/h) and adjusting for covariates and relatedness, RNadist was lower in DRD194GG homozygotes than –94A allele carriers (effect size, –0.94%; P=0.005) with opposite findings for FENa (+0.084%; P=0.014). AGC carriers (–0.88%; P=0.012) and AAC carriers (+1.00%; P=0.004) had different RNadist compared to corresponding noncarriers. Furthermore, FENa was lower in AAC carriers than in noncarriers (–0.082%; P=0.019). The family-based analyses identified a significant between-family component in the variance of the renal phenotypes associated with the DRD1 polymorphisms. Transmission of the DRD1 AGC haplotype was also associated with lower systolic (–3.54 mm Hg; P=0.016) and diastolic (–2.80 mm Hg; P=0.0064) BPs without significant between-family variance component. Plasma renin activity and urinary aldosterone excretion were not associated with DRD1 variation. The GRK4 Ala142Val polymorphism did not contribute to the phenotypes under study. In conclusion, renal sodium handling and BP were associated with genetic variation in the DRD1 promoter. The between-family variance component excluded population stratification for BP, but not for the renal phenotypes.


Key Words: blood pressure • clinical genetics • dopamine receptor gene • GRK4 • lithium clearance • population science • tubular transport




This article has been cited by other articles:


Home page
HypertensionHome page
Y. Jin, T. Kuznetsova, M. Maillard, T. Richart, L. Thijs, M. Bochud, M.-C. Herregods, M. Burnier, R. Fagard, and J. A. Staessen
Independent Relations of Left Ventricular Structure With the 24-Hour Urinary Excretion of Sodium and Aldosterone
Hypertension, September 1, 2009; 54(3): 489 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Mayan, S. Melnikov, I. Novikov, E. J. Holtzman, and Z. Farfel
Familial Hyperkalemia and Hypertension: Pathogenetic Insights Based on Lithium Clearance
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3010 - 3016.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. W. Sanders
Dietary Salt Intake, Salt Sensitivity, and Cardiovascular Health
Hypertension, March 1, 2009; 53(3): 442 - 445.
[Full Text] [PDF]


Home page
HypertensionHome page
P. A. Doris
Promoting Regulatory Gene Variation in Sodium Reabsorption
Hypertension, October 1, 2008; 52(4): 623 - 624.
[Full Text] [PDF]


Home page
HypertensionHome page
Y. Jin, T. Kuznetsova, V. Tikhonoff, M. Maillard, M. Bochud, M. Burnier, S. Hasenkamp, E. Brand, S.-M. Brand-Herrmann, T. Richart, et al.
Segmental Renal Sodium Handling in Relation to the Human SAH Gene
Hypertension, August 1, 2008; 52(2): e12 - e13.
[Full Text] [PDF]